-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$57.2773.76% Upside
Recent Analyst Forecasts and Stock Ratings
Guardant Health, Inc. Frequently Asked Questions
-
What analysts cover Guardant Health, Inc.?
Guardant Health, Inc. has been rated by research analysts at UBS, Craig-Hallum, Jefferies, BTIG, Guggenheim, Canaccord Genuity in the past 90 days.